LHC Group (NASDAQ:LHCG) had its price target reduced by investment analysts at Deutsche Bank Aktiengesellschaft from $260.00 to $245.00 in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a “buy” rating on the health services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective indicates a potential upside of 48.19% from the company’s current price.
A number of other equities analysts have also recently commented on LHCG. Cowen initiated coverage on LHC Group in a report on Thursday, September 9th. They issued an “outperform” rating and a $209.00 target price on the stock. Barclays downgraded LHC Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $245.00 to $207.00 in a research note on Thursday, August 12th. Benchmark boosted their price objective on LHC Group from $250.00 to $260.00 and gave the company a “buy” rating in a research note on Friday, July 9th. Finally, Credit Suisse Group decreased their target price on shares of LHC Group from $255.00 to $252.00 and set an “outperform” rating on the stock in a research note on Tuesday, August 10th. One research analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of $236.25.
Shares of NASDAQ LHCG traded up $0.10 during midday trading on Wednesday, hitting $165.33. 2,069 shares of the company’s stock traded hands, compared to its average volume of 180,249. The firm has a fifty day moving average of $188.30 and a 200 day moving average of $195.39. LHC Group has a 1 year low of $164.00 and a 1 year high of $236.81. The stock has a market capitalization of $5.24 billion, a price-to-earnings ratio of 44.30, a price-to-earnings-growth ratio of 1.93 and a beta of 0.36.
A number of hedge funds and other institutional investors have recently bought and sold shares of LHCG. Cullen Frost Bankers Inc. lifted its stake in LHC Group by 568.6% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 234 shares of the health services provider’s stock worth $47,000 after purchasing an additional 199 shares in the last quarter. Eubel Brady & Suttman Asset Management Inc. bought a new stake in shares of LHC Group in the second quarter worth about $57,000. Heritage Wealth Management LLC lifted its position in shares of LHC Group by 55.1% in the second quarter. Heritage Wealth Management LLC now owns 307 shares of the health services provider’s stock worth $61,000 after buying an additional 109 shares in the last quarter. Van ECK Associates Corp purchased a new stake in shares of LHC Group in the second quarter worth about $74,000. Finally, Advisory Services Network LLC bought a new position in LHC Group during the second quarter valued at approximately $94,000. 92.14% of the stock is currently owned by institutional investors.
LHC Group Company Profile
LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.
Read More: How Buying a Call Option Works
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.